B cell-deficient NOD.H-2h4 mice have CD4+CD25+ T regulatory cells that inhibit the development of spontaneous autoimmune thyroiditis

Journal of Experimental Medicine

Volumn 203, Issue 2, 2006, Pages 349-358

  Yu, Shiguang ^a   Maiti, Prasanta K ^a   Dyson, Melissa ^b   Jain, Renu ^a   Braley Mullen, Helen ^a,b  

^a University of Missouri   (United States)

^b UNIVERSITY OF MISSOURI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; AUTOANTIGEN; BASILIXIMAB; IMMUNOGLOBULIN; SODIUM IODIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ANTIGEN PRESENTATION; ARTICLE; B LYMPHOCYTE; CD25+ T LYMPHOCYTE; CD4+ CD25+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE SEVERITY; FEMALE; HASHIMOTO DISEASE; IMMUNE RESPONSE; IMMUNOGLOBULIN PRODUCTION; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; T LYMPHOCYTE ACTIVATION; TRANSGENIC MOUSE; WILD TYPE;

ANIMALS; ANTIBODIES, MONOCLONAL; B-LYMPHOCYTES; CELLS, CULTURED; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; IMMUNOGLOBULINS; LYMPHOCYTE COUNT; LYMPHOPENIA; MALE; MICE; MICE, INBRED NOD; MICE, TRANSGENIC; RECEPTORS, INTERLEUKIN-2; T-LYMPHOCYTES, REGULATORY; THYROIDITIS, AUTOIMMUNE;

EID: 33344474600     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.20051438     Document Type: Article

References (53)

1. Braley-Mullen, H., G.C. Sharp, B. Medling, and H. Tang. 1999. Spontaneous thyroiditis in NOD.H-2h4 mice. J. Autoimmun. 12:157-165.
2. Rasooly, L., C.L. Burek, and N.R. Rose. 1996. Iodine-induced autoimmune thyroiditis in NOD.H-2h4 mice. Clin. Immunol. Immunopathol. 81:287-292.
3. Hutchings, P., S. Verma, J.M. Phillips, S.Z. Harach, S. Howlett, and A. Cooke. 1999. Both CD4+ and CD8+ T cells are required for iodine accelerated thyroiditis in NOD.H-2h4 mice. Cell. Immunol. 192:113-121.
4. Yu, S., B. Medling, H. Yagita, and H. Braley-Mullen. 2001. Characteristics of inflammatory cells in spontaneous autoimmune thyroiditis of NOD.H-2h4 mice. J. Autoimmun. 16:37-46.
5. Braley-Mullen, H., and S. Yu. 2000. Early requirement for B cells for development of spontaneous autoimmune thyroiditis in NOD.H-2h4 mice. J. Immunol. 165:7262-7269.
6. Bonita, R.E., N.R. Rose, L. Rasooly, P. Caturegli, and C.L. Burek. 2003. Kinetics of mononuclear cell infiltration and cytokine expression in iodine-induced thyroiditis in the NOD.H-2h4 mouse. Exp. Mol. Pathol. 74:1-12.
7. Shevach, E. 2000. Regulatory T cells in autoimmunity. Annu. Rev. Immunol. 18:423-449.
8. Piccirillo, C.A., and E.M. Shevach. 2004. Naturally-occurring CD4+ CD25+ immunoregulatory T cells: central players in the arena of peripheral tolerance. Semin. Immunol. 16:81-88.
9. Fehervari, Z., and S. Sakaguchi. 2004. CD4+ T regs and immune control. J. Clin. Invest. 114:1209-1217.
10. Serreze, D.V., S.A. Fleming, H.D. Chapman, S.D. Richard, E.H. Leiter, and R.M. Tisch. 1998. B lymphocytes are critical antigen-presenting cells for the initiation of T cell-mediated autoimmune diabetes in non-obese diabetic mice. J. Immunol. 161:3912-3918.
11. Noorchashm, H., Y.K. Lieu, N. Noorchashm, S.Y. Rostani, S.A. Greeley, A. Schlachterman, H.K. Song, L.E. Noto, L.E. Jevnikar, C.F. Barker, and A. Naji. 1999. I-Ag7-mediated antigen presentation by B lymphocytes is critical in overcoming a checkpoint in T cell tolerance to islet β cells of nonobese diabetic mice. J. Immunol. 163:743-750.
12. Chan, O.T., L.G. Hannum, A.M. Haberman, M.P. Madaio, and M. Shlomchik. 1999. A novel mouse with B cells but lacking serum antibody reveals an antibody-independent role for B cells in murine lupus. J. Exp. Med. 189:1639-1647.
13. Chan, O., and M.J. Shlomchik. 1999. The central and specific roles of B cells in lupus pathogenesis. Immunol. Rev. 169:107-121.
14. Svensson, L., J. Jiholt, R. Holmdahl, and L. Jansson. 1998. B cell-deficient mice do not develop type II collagen-induced arthritis (CIA). Clin. Exp. Immunol. 111:521-526.
15. Matsumoto, I., M. Maccioni, D.M. Lee, M. Maurice, B. Simmons, M. Brenner, D. Mathis, and C. Benoist. 2002. How antibodies to a ubiquitous cytoplasmic enzyme may provoke joint-specific autoimmune disease. Nat. Immunol. 3:360-365.
16. Lyons, J., M. San, M.P. Happ, and A.H. Cross. 1999. B cells are critical to induction of experimental allergic encephalomyelitis by protein but not by a short encephalitogenic peptide. Eur. J. Immunol. 29:3432-3439.
17. Rodriguez-Pinto, D., and J. Moreno. 2005. B cells can prime naive CD4+ T cells in vivo in the absence of other professional antigen-presenting cells in a CD154-CD40-dependent manner. Eur. J. Immunol. 35:1097-1105.
18. Silveira, P.A., E. Johnson, H.D. Chapman, T. Bui, R.M. Tisch, and D.V. Serreze. 2002. The preferential ability of B lymphocytes to act as diabetogenic APC in NOD mice depends on expression of self-antigen-specific immunoglobulin receptors. Eur. J. Immunol. 32:3657-3666.
19. Silveira, P.A., J. Dombrowsky, E. Johnson, H.D. Chapman, D. Nemazee, and D.V. Serreze. 2004. B cell selection defects underlie the development of diabetogenic APCs in nonobese diabetic mice. J. Immunol. 172:5086-5094.
20. O'Neill, S.K., M.J. Shlomchik, T.T. Glant, Y. Cao, P.D. Doodes, and A. Finnegan. 2005. Antigen-specific B cells are required as APCs and autoantibody-producing cells for induction of severe autoimmune arthritis. J. Immunol. 174:3781-3788.
21. Sakaguchi, S. 2004. Naturally arising CD4+ regulatory T cells for immunologic self-tolerance and negative control of immune responses. Annu. Rev. Immunol. 22:531-562.
22. Asano, M., M. Toda, N. Sakaguchi, and S. Sakaguchi. 1996. Autoimmune disease as a consequence of developmental abnormality of a T cell population. J. Exp. Med. 184:387-396.
23. + regulatory cells constitutively expressing CTLA-4. J. Exp. Med. 192:303-310.
24. Yu, S., G.C. Sharp, and H. Braley-Mullen. 2002. Dual roles for IFNγ, but not for IL-4, in spontaneous autoimmune thyroiditis in NOD.H-2h4 mice. J. Immunol. 169:3999-4007.
25. McLachlan, S.M., H. Braley-Mullen, C.R. Chen, H. Aliesky, P.N. Pichurin, and B. Rapoport. 2005. Dissociation between iodide-induced thyroiditis and antibody-mediated hyperthyroidism in NOD.H-2h4 mice. Endocrinology. 146:294-300.
26. Goldrath, A.W., C.J. Luckey, R. Park, C. Benoist, and D. Mathis. 2004. The molecular program induced in T cells undergoing homeostatic proliferation. Proc. Natl. Acad. Sci. USA. 101:16885-16890.
27. McHugh, R.S., and E.M. Shevach. 2002. Cutting edge: depletion of CD4+CD25+ regulatory cells is necessary, but not sufficient, for induction of organ-specific autoimmune disease. J. Immunol. 168:5979-5983.
28. Chiu, P., D.V. Serreze, and J.S. Danska. 2001. Development and function of diabetogenic T cells in B cell-deficient nonobese diabetic mice. Diabetes. 50:763-770.
29. Suri-Payer, E., K. Wei, and K. Tung. 1999. The day 3 thymectomy model of organ-specific autoimmunity (Unit 15.16). In Current Protocols in Immunology. J.E. Coligan, A.M. Kruisbeek, D.H. Margulies, E.M. Shevach, and W. Strober, editors. John Wiley and Sons, Inc., New York.
30. Alard, P., C. Thompson, S.S. Agersborg, J. Thatte, Y. Setiady, E. Samy, and K.S.K. Tung. 2001. Endogenous oocyte antigens are required for rapid induction and progression of autoimmune ovarian disease following day-3 thymectomy. J. Immunol. 166:4363-4369.
31. Sakaguchi, S. 2005. Naturally arising Foxp3-expressing CD25+ CD4+ regulatory T cells in immunological tolerance to self and non-self. Nat. Immunol. 6:345-352.
32. Fontenot, J.D., and A.Y. Rudensky. 2005. A well adapted regulatory contrivance: regulatory T cell development and the forkhead family transcription factor Foxp 3. Nat. Immunol. 6:331-337.
33. Khattri, R., T. Cox, S.A. Yasayko, and F. Ramsdell. 2003. An essential role for Scurfin in CD4+CD25+ T regulatory cells. Nat. Immunol. 4:337-342.
34. Fontenot, J.D., J.P. Rasmussen, L.M. Williams, J.L. Dooley, A.G. Farr, and A.Y. Rudensky. 2005. Regulatory T cell lineage specification by the forkhead transcription factor Foxp 3. Immunity. 22:329-341.
35. Gregg, R.K., R. Jain, S.J. Schoenleber, R. Divekar, J.J. Bell, H. Lee, P. Yu, and H. Zaghouani. 2004. A sudden decline in active membrane-bound TGF-β impairs both regulatory T cell function and protection against autoimmune diabetes. J. Immunol. 173:7308-7316.
36. Myers, K.J., J. Sprent, J.P. Dougherty, and Y. Ron. 1992. Synergy between encephalitogenic T cells and myelin basic protein-specific antibodies in the induction of experimental autoimmune encephalomyelitis. J. Neuroimmunol. 41:1-8.
37. Tung, K.S.K., S.S. Agersborg, P. Alard, K.M. Garza, and Y.H. Lou. 2001. Regulatory T-cell, endogenous antigen and neonatal environment in the prevention and induction of autoimmune disease. Immunol. Rev. 182:135-148.
38. Olson, T.S., G. Bamias, M. Naganuma, J. Rivera-Nieves, T.L. Burcin, W. Rose, M.A. Morris, T.T. Pizarro, P.B. Ernst, F. Cominelli, and K. Ley. 2004. Expanded B cell population blocks regulatory T cells and exacerbates ileitis in a murine model of Crohn disease. J. Clin. Invest. 114:389-398.
39. Tone, M., Y. Tone, E. Adams, S.F. Yates, M.R. Frewin, S.P. Cobbold, and H. Waldmann. 2003. Mouse glucorticoid-induced tumor necrosis factor receptor ligand is costimulatory for T cells. Proc. Natl. Acad. Sci. USA. 100:15059-15065.
40. Stephens, G.L., R.S. McHugh, M.J. Whitters, D.A. Young, D. Luxenberg, B.M. Carreno, M. Collins, and E.M. Shevach. 2004. Engagement of glucocorticoid-induced TNFR family-related receptor on effector T cells by its ligand mediates resistance to suppression by CD4+CD25+ T cells. J. Immunol. 173:5008-5020.
41. Ji, H., G. Liao, W.A. Faubion, A.C. Abadia-Molina, C. Cozzo, F.S. Laroux, A. Caton, and C. Terhorst. 2004. Cutting edge: the natural ligand for glucorticoid-induced TNF receptor-related protein abrogates regulatory T cell suppression. J. Immunol. 172:5823-5827.
42. Yu, K., H.S. Kim, S.Y. Song, S. Min, J.J. Jeong, and B.S. Youn. 2003. Identification of a ligand for glucocorticoid-induced tumor necrosis factor receptor constitutively expressed in dendritic cells. Biochem. Biophys. Res. Commun. 310:433-438.
43. Wong, F.S., L. Wen, M. Tang, M. Ramanathan, I. Visintin, J. Daugherty, L.G. Hannum, C.A. Janeway Jr., and M.J. Schlomchik. 2004. Investigation of the role of B-cells in type 1 diabetes in the NOD mouse. Diabetes. 53:2581-2587.
44. Baker, N., and M.R. Ehrenstein. 2002. Cutting edge: selection of B lymphocyte subsets is regulated by natural IgM. J. Immunol. 169:6686-6690.
45. Morris, G.P., L. Chen, and Y.M. Kong. 2003. CD137 signaling interferes with activation and function of CD4+CD25+ regulatory T cells in induced tolerance to experimental autoimmune thyroiditis. Cell. Immunol. 226:20-29.
46. Morris, G.P., Y. Yan, C.S. David, and Y.M. Kong. 2005. H2A- and H2E-derived CD4+CD25+ regulatory T cells: a potential role in reciprocal inhibition by class II genes in autoimmune thyroiditis. J. Immunol. 174:3111-3116.
47. Gangi, E., C. Vasu, D. Cheatem, and B.S. Prabhakhar. 2005. IL-10 producing CD4+CD25+ regulatory T cells play a critical role in granulocyte macrophage-colony stimulating factor-induced suppression of experimental autoimmune thyroiditis. J. Immunol. 174:7006-7013.
48. Verginis, P., H.S. Li, and G. Carayanniotis. 2005. Tolerogenic semi-mature dendritic cells suppress experimental thyroiditis by activation of thyroglobulin-specific CD4+CD25+ T cells. J. Immunol. 174:7433-7439.
49. Sempowski, G.D., S.J. Cross, C.S. Heinly, R.M. Scearce, and B.F. Haynes. 2004. CD7 and CD28 are required for murine CD4+CD25+ regulatory T cell homeostasis and prevention of thyroiditis. J. Immunol. 172:787-794.
50. Heath, V.L., N.C. Moore, S. Parnell, and D.W. Mason. 1998. Intrathymic expression of genes involved in organ-specific autoimmune disease. J. Autoimmun. 11:309-318.
51. Li, H., and G. Carayanniotis. 2005. Detection of thyroglobulin mRNA as truncated isoform(s) in mouse thymus. Immunology. 115:85-89.
52. Seddon, B., and D.W. Mason. 1999. Peripheral autoantigen induces regulatory T cells that prevent autoimmunity. J. Exp. Med. 189:877-882.
53. Hori, S., T. Nomura, and S. Sakaguchi. 2003. Control of regulatory T cell development by the transcription factor Foxp3. Science. 299:1057-1061.